SWK Holdings provides portfolio update
Recent Financial Advances: SWK provided various financial advances in November and December, including $5.0M to Journey Medical for Emrosi's launch, $8.0M to Triple Ring Technologies, and a $25.7M expansion of credit for Eton, among others.
Repayments Received: SWK received significant repayments totaling over $40M from various sources, including Biolase's bankruptcy estate and sales of assets, with additional payments anticipated in 2025.
Trade with 70% Backtested Accuracy
Analyst Views on SWKH
About SWKH
About the author
Runway Growth Finance Acquires SWK Holdings to Scale Portfolio
- Portfolio Contraction: Runway Growth Finance's portfolio fair value decreased from $1.02 billion to $946 million, indicating a strategic contraction while integrating BC Partners to broaden sourcing channels, thereby laying the groundwork for future investment activities.
- SWK Holdings Acquisition: The company announced its acquisition of SWK Holdings, expected to add approximately $242 million to the portfolio, increasing healthcare and life sciences exposure from 14% to roughly 31%, significantly enhancing the company's earnings power and financial profile.
- Dividend Adjustment: The quarterly dividend has been reduced from $0.47 per share in early 2024 to $0.33, yet the Q3 net interest income of $0.43 per share still covers the current dividend at a 1.30x ratio, demonstrating stability in earnings.
- Future Outlook: Despite facing pressure from falling interest rates, CEO Spreng emphasized that the deal flow from BC Partners and the SWK acquisition will be primary drivers of future portfolio growth, with expectations for mid-single-digit net interest income accretion in the first full quarter post-acquisition expected to close in early 2026.
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders
Investigation of Companies: Halper Sadeh LLC is investigating SWK Holdings Corporation, 89bio, Inc., Barinthus Biotherapeutics plc, and Verint Systems Inc. for potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to their recent transactions.
Shareholder Rights and Options: The law firm encourages shareholders of the mentioned companies to contact them for information on their legal rights and options, emphasizing that they operate on a contingent fee basis, meaning no upfront legal fees are required.
BRODSKY & SMITH INVESTOR ALERT: Updates on Investigations Involving TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), and SWK Holdings Corporation (Nasdaq – SWKH)
TrueCar Acquisition Investigation: TrueCar, Inc. is set to be acquired by Fair Holdings for $2.55 per share, prompting an investigation into whether the Board breached fiduciary duties by not ensuring a fair process and value for shareholders.
Astria Therapeutics Merger Scrutiny: Astria Therapeutics, Inc. will be acquired by BioCryst Pharmaceuticals for an implied value of $13.00 per share, leading to an investigation regarding the Board's adherence to fiduciary duties in the merger process.
PotlatchDeltic Corporation Deal Review: PotlatchDeltic Corporation is being acquired by Rayonier, with shareholders receiving shares valued at $44.11 each, raising concerns about the Board's fiduciary responsibilities in ensuring fair value during the transaction.
SWK Holdings Corporation Acquisition Inquiry: SWK Holdings Corporation will merge with Runway Growth Finance Corp. in a deal valued at approximately $220 million, with investigations focusing on the Board's duty to conduct a fair process and provide adequate value to shareholders.
VTI ETF Daily Update: Key Information for Investors – 10/15/2025
VTI Stock Performance: The Vanguard Total Stock Market ETF (VTI) is down 1.25% over the past week but has increased by 13.86% year-to-date, with a slight decline of 0.03% on Tuesday amidst market volatility due to geopolitical tensions.
Investor Activity and Analyst Ratings: VTI saw a net inflow of $218 million over the last five days, and analysts rate it as a Moderate Buy with a price target of $372.45, suggesting a potential upside of 14%.
SHAREHOLDER RIGHTS NOTICE: Halper Sadeh LLC Probes EA, HSII, SWKH for Shareholder Interests
Investigation of Companies: Halper Sadeh LLC is investigating Electronic Arts Inc., Heidrick & Struggles International, Inc., and SWK Holdings Corporation for potential violations of federal securities laws and breaches of fiduciary duties related to their recent sales to investor consortia.
Shareholder Rights and Legal Support: The firm offers free consultations to shareholders regarding their rights and options, and may seek increased compensation or additional disclosures on behalf of shareholders, operating on a contingent fee basis.
SWK Holdings Shares Surge 15% Amid High Trading Volume
Stock Performance: SWK Holdings Corp. (SWKH) experienced a significant increase of 15.97%, closing at $16.70 after opening at $14.42 and reaching a high of $16.75 during the day.
Merger Announcement: The surge in stock price follows the announcement of a NAV-for-NAV merger deal with Runway Growth Finance, valued at approximately $220 million, which has generated strong investor interest reflected in higher trading volume.
Runway Growth Finance Acquires SWK Holdings to Scale Portfolio
- Portfolio Contraction: Runway Growth Finance's portfolio fair value decreased from $1.02 billion to $946 million, indicating a strategic contraction while integrating BC Partners to broaden sourcing channels, thereby laying the groundwork for future investment activities.
- SWK Holdings Acquisition: The company announced its acquisition of SWK Holdings, expected to add approximately $242 million to the portfolio, increasing healthcare and life sciences exposure from 14% to roughly 31%, significantly enhancing the company's earnings power and financial profile.
- Dividend Adjustment: The quarterly dividend has been reduced from $0.47 per share in early 2024 to $0.33, yet the Q3 net interest income of $0.43 per share still covers the current dividend at a 1.30x ratio, demonstrating stability in earnings.
- Future Outlook: Despite facing pressure from falling interest rates, CEO Spreng emphasized that the deal flow from BC Partners and the SWK acquisition will be primary drivers of future portfolio growth, with expectations for mid-single-digit net interest income accretion in the first full quarter post-acquisition expected to close in early 2026.
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders
Investigation of Companies: Halper Sadeh LLC is investigating SWK Holdings Corporation, 89bio, Inc., Barinthus Biotherapeutics plc, and Verint Systems Inc. for potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to their recent transactions.
Shareholder Rights and Options: The law firm encourages shareholders of the mentioned companies to contact them for information on their legal rights and options, emphasizing that they operate on a contingent fee basis, meaning no upfront legal fees are required.
BRODSKY & SMITH INVESTOR ALERT: Updates on Investigations Involving TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), and SWK Holdings Corporation (Nasdaq – SWKH)
TrueCar Acquisition Investigation: TrueCar, Inc. is set to be acquired by Fair Holdings for $2.55 per share, prompting an investigation into whether the Board breached fiduciary duties by not ensuring a fair process and value for shareholders.
Astria Therapeutics Merger Scrutiny: Astria Therapeutics, Inc. will be acquired by BioCryst Pharmaceuticals for an implied value of $13.00 per share, leading to an investigation regarding the Board's adherence to fiduciary duties in the merger process.
PotlatchDeltic Corporation Deal Review: PotlatchDeltic Corporation is being acquired by Rayonier, with shareholders receiving shares valued at $44.11 each, raising concerns about the Board's fiduciary responsibilities in ensuring fair value during the transaction.
SWK Holdings Corporation Acquisition Inquiry: SWK Holdings Corporation will merge with Runway Growth Finance Corp. in a deal valued at approximately $220 million, with investigations focusing on the Board's duty to conduct a fair process and provide adequate value to shareholders.
VTI ETF Daily Update: Key Information for Investors – 10/15/2025
VTI Stock Performance: The Vanguard Total Stock Market ETF (VTI) is down 1.25% over the past week but has increased by 13.86% year-to-date, with a slight decline of 0.03% on Tuesday amidst market volatility due to geopolitical tensions.
Investor Activity and Analyst Ratings: VTI saw a net inflow of $218 million over the last five days, and analysts rate it as a Moderate Buy with a price target of $372.45, suggesting a potential upside of 14%.
SHAREHOLDER RIGHTS NOTICE: Halper Sadeh LLC Probes EA, HSII, SWKH for Shareholder Interests
Investigation of Companies: Halper Sadeh LLC is investigating Electronic Arts Inc., Heidrick & Struggles International, Inc., and SWK Holdings Corporation for potential violations of federal securities laws and breaches of fiduciary duties related to their recent sales to investor consortia.
Shareholder Rights and Legal Support: The firm offers free consultations to shareholders regarding their rights and options, and may seek increased compensation or additional disclosures on behalf of shareholders, operating on a contingent fee basis.
SWK Holdings Shares Surge 15% Amid High Trading Volume
Stock Performance: SWK Holdings Corp. (SWKH) experienced a significant increase of 15.97%, closing at $16.70 after opening at $14.42 and reaching a high of $16.75 during the day.
Merger Announcement: The surge in stock price follows the announcement of a NAV-for-NAV merger deal with Runway Growth Finance, valued at approximately $220 million, which has generated strong investor interest reflected in higher trading volume.
